Stay updated on Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH operations was added, and the page shows a version update from v3.4.0 to v3.4.1. These updates do not alter the trial details or data presented.
    Difference
    0.4%
    Check dated 2026-02-04T05:22:21.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    UI changes include adding a glossary toggle, introducing result-status labels (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) and a No FEAR Act Data notice, plus a Revision: v3.4.0; older labels such as Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T02:13:03.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4; there are no changes to study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:17:30.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing the Texas site and updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T13:31:24.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no substantive changes to the study details are visible.
    Difference
    0.1%
    Check dated 2025-12-01T18:53:45.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.3.1; Revision: v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T15:09:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.